Genetic Testing Costly, Hard to Access, Survey Shows

Genetic Testing Costly, Hard to Access, Survey Shows

306187

Genetic Testing Costly, Hard to Access, Survey Shows

High prices, lack of access, and long waiting times are major barriers to people who want to undergo genetic testing for Parkinson’s disease, according to a survey by the International Parkinson and Movement Disorder Society (MDS). Survey results will be presented at the MDS Virtual Congress 2021, held online Sept. 17–22, in a presentation titled “MDS Survey of Genetic Testing and Counseling Practices for Parkinson Disease.” Mutations in certain genes, such as LRRK2 and GBA, are associated with an…

You must be logged in to read/download the full post.